Cargando…

The prediagnostic phase of Parkinson's disease

The field of prediagnostic Parkinson's disease (PD) is fast moving with an expanding range of clinical and laboratory biomarkers, and multiple strategies seeking to discover those in the earliest stages or those ‘at risk’. It is widely believed that the highest likelihood of securing neuroprote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noyce, Alastair John, Lees, Andrew John, Schrag, Anette-Eleonore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Movement Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975823/ https://www.ncbi.nlm.nih.gov/pubmed/26848171 http://dx.doi.org/10.1136/jnnp-2015-311890

Ejemplares similares

Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank
por: Jacobs, Benjamin Meir, et al.
Publicado: (2020)

Brain iron deposition is linked with cognitive severity in Parkinson’s disease
por: Thomas, George Edward Calver, et al.
Publicado: (2020)

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results
por: Noyce, Alastair J, et al.
Publicado: (2014)

Subtle motor disturbances in PREDICT-PD participants
por: Noyce, Alastair J, et al.
Publicado: (2017)

Bone health in Parkinson's disease: a systematic review and meta-analysis
por: Torsney, Kelli M, et al.
Publicado: (2014)

Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study
por: Kazmi, Hiba, et al.
Publicado: (2021)

Pisa syndrome in Parkinson's disease: a mobile or fixed deformity?
por: Doherty, Karen M, et al.
Publicado: (2013)

Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)

Combining biomarkers for prognostic modelling of Parkinson’s disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

Using ‘dead or dependent’ as an outcome measure in clinical trials in Parkinson's disease
por: McGhee, David, et al.
Publicado: (2015)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

How I treat Parkinson's disease
por: Barbosa, Egberto Reis, et al.
Publicado: (2022)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

Cortical thinning is associated with disease stages and dementia in Parkinson's disease
por: Zarei, Mojtaba, et al.
Publicado: (2013)

Clinical implications of early caudate dysfunction in Parkinson’s disease
por: Pasquini, Jacopo, et al.
Publicado: (2019)

Bilateral adaptive deep brain stimulation is effective in Parkinson's disease
por: Little, Simon, et al.
Publicado: (2016)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)

Validation of new diagnostic criteria for fatigue in patients with Parkinson disease
por: Siciliano, Mattia, et al.
Publicado: (2022)

Systematic review of data‐driven cognitive subtypes in Parkinson disease
por: Pourzinal, Dana, et al.
Publicado: (2022)

The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism
por: Klebe, Stephan, et al.
Publicado: (2013)

Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
por: Xiao, Bin, et al.
Publicado: (2016)

Comparative whole transcriptome analysis of Parkinson’s disease focusing on the efficacy of zonisamide
por: Naito, Tatsuhiko, et al.
Publicado: (2022)

Deep brain stimulation in Parkinson’s disease: state of the art and future perspectives
por: França, Carina, et al.
Publicado: (2022)

Efficacy of intensive multidisciplinary rehabilitation in Parkinson’s disease: a randomised controlled study
por: Ferrazzoli, Davide, et al.
Publicado: (2018)

Long‐term independence and quality of life after subthalamic stimulation in Parkinson disease
por: Castrioto, Anna, et al.
Publicado: (2022)

Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease
por: Sauerbier, Anna, et al.
Publicado: (2021)

Magnetic resonance and dopamine transporter imaging for the diagnosis of Parkinson´s disease: a narrative review
por: Otani, Rafael Tomio Vicentini, et al.
Publicado: (2022)

Visual dysfunction is a better predictor than retinal thickness for dementia in Parkinson’s disease
por: Hannaway, Naomi, et al.
Publicado: (2023)

Visual hallucinations in the differential diagnosis of parkinsonism
por: Bertram, Kelly, et al.
Publicado: (2012)

Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis
por: Moisan, Frédéric, et al.
Publicado: (2016)

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort
por: Simuni, Tanya, et al.
Publicado: (2018)

Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson’s disease
por: Lo, Christine, et al.
Publicado: (2022)

Prevalence and genotype–phenotype correlations of GBA‐related Parkinson disease in a large Chinese cohort
por: Ren, Jingru, et al.
Publicado: (2022)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

From trials to clinical practice: Temporal trends in the coverage of specialized allied health services for Parkinson's disease
por: Bloem, Bastiaan R., et al.
Publicado: (2020)

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?
por: Weil, Rimona S., et al.
Publicado: (2018)

Prognostic predictors relevant to end-of-life palliative care in Parkinson’s disease and related disorders: a systematic review
por: Akbar, Umer, et al.
Publicado: (2021)

REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease
por: Rolinski, Michal, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6u6p4v3lqdvnoftrhi6gdk8q74